O2-11-2 - A phase II study of low-dose erlotinib in frail patients with EGFR-mutant non-small cell lung cancer: TORG1425

Akihiro Bessho, Shingo Miyamoto + Show 12 more

Open Access

https://doi.org/10.1093/annonc/mdy374.034

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Oct 1, 2018
License type: publisher-specific-oa

Affiliation: Okayama Red Cross General Hospital, Japanese Red Cross Medical Center, Kurume University, Yokohama Municipal Citizen's Hospital, Niigata Cancer Center Hospital, Mitsui Memorial Hospital, Kitasato University, Tokyo Metropolitan Komagome Hospital, Tokyo National Hospital

#EGFR-mutant Non-small Cell Lung Cancer #Frail Patients + Show 4 more

Abstract
Full-Text PDF
Similar Papers

Abstract

O2-11-2 - A phase II study of low-dose erlotinib in frail patients with EGFR-mutant non-small cell lung cancer: TORG1425

Full Text

Published version (

Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title

Journal

Date

Author

View more papers

Translate this paper in your preferred language
Listen to the abstract of this paper

Save
Share
Export